KaloBios offered financing in plan to buy drug for Chagas disease
Brooklyn
KALOBIOS Pharmaceuticals Inc, the drug company that plunged into bankruptcy after the arrest of its former chief executive officer Martin Shkreli, is getting some help for its plan to buy a treatment for Chagas disease.
Hedge fund Black Horse Capital LP offered to buy at least 40 per cent of the company for US$10 million on the condition that Shkreli holds no more than 20 per cent of KaloBios' voting shares, according to a filing on Thursday in Delaware bankruptcy court. Shkreli had owned about 50 per cent of the stock before the bankruptcy. At least a substantial portion of his stake was used to secure his US$5 million bail after he was charged with securities fraud in December.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Keppel Infrastructure Trust posts 29.1% lower Q1 distributable income
Elite Commercial Reit’s Q1 DPU down 21.2% to £0.0067
Airbus called for compensation to take on money-losing Spirit operations: sources
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Booking says room reservations to slow amid Middle-East conflict
Deutsche Bank unveils wealth targets after hiring push in Asia